Unstable Angina Pectoris With Myocardial Injury Versus Myocardial Infarction in the Era of High-Sensitivity Cardiac
Andreas Roos1, Gustaf Edgren2, Martin J Holzmann1
1Department of Medicine; Department of Emergency and Reparative Medicine, Karolinska University Hospital, Stockholm, Sweden.
Insights
Patients with unstable angina pectoris (UAP) and myocardial injury have similar long-term mortality as non-ST-segment myocardial infarction (NSTEMI) patients. However, UAP patients show a lower risk of recurrent myocardial infarction and slightly higher heart failure risk.
Area of Science:
- Cardiology
- Clinical Medicine
- Biomarkers
Background:
- Unstable angina pectoris (UAP) and non-ST-segment myocardial infarction (NSTEMI) are critical cardiovascular conditions.
- The prognostic implications of myocardial injury in UAP versus NSTEMI with varying peak high-sensitivity cardiac troponin T (hs-cTnT) levels remain unclear.
Purpose of the Study:
- To compare the long-term prognosis of patients diagnosed with UAP and myocardial injury against patients with NSTEMI.
- To analyze outcomes based on different peak hs-cTnT concentrations in NSTEMI patients.
Main Methods:
- Retrospective cohort study utilizing data from 7 Swedish emergency departments (2009-2016).
- Inclusion criteria: hospitalized patients with hs-cTnT >14 ng/L and diagnoses of UAP or NSTEMI, with at least two hs-cTnT measurements.
- Outcomes assessed: all-cause mortality, cardiovascular events, recurrent myocardial infarction, and heart failure hospitalization, analyzed using hazard ratios (HRs).
Main Results:
- A total of 11,944 patients were included (1,253 with UAP).
- No significant difference in long-term cardiovascular mortality between UAP patients and NSTEMI patients with peak hs-cTnT of 15-49 ng/L (HR 1.15; 95% CI, 0.85-1.56).
- NSTEMI patients had a higher risk of recurrent myocardial infarction (HR 1.61; 95% CI, 1.29-2.00) and a lower risk of heart failure hospitalization (HR 0.80; 95% CI, 0.64-0.99) compared to UAP patients.
Conclusions:
- Patients with UAP and myocardial injury exhibit comparable long-term mortality rates to NSTEMI patients with moderately elevated hs-cTnT.
- UAP patients demonstrate a reduced risk of recurrent myocardial infarction but a slightly increased risk of heart failure hospitalization post-discharge.
- These findings highlight distinct prognostic trajectories for UAP and NSTEMI, informing clinical management strategies.
Abstract:
It is unknown whether outcomes in patients with unstable angina pectoris (UAP) and myocardial injury are different from outcomes in patients with non-ST-segment myocardial infarction (NSTEMI) with low peak concentrations of high-sensitivity cardiac troponin T (hs-cTnT). This study aimed to compare the prognosis in patients with UAP and evidence of myocardial injury, with prognosis in patients with NSTEMI and different peak hs-cTnT concentrations. All visits to 7 different emergency departments in Sweden from December 9, 2009 to December 31, 2016 were identified (n = 5,225,075). We included all hospitalized patients with hs-cTnT >14 ng/L and a diagnosis of UAP or NSTEMI, with ≥2 hours-cTnT measurements. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated for all-cause mortality and cardiovascular events, in patients with NSTEMI categorized according to peak hs-cTnT concentrations, compared with patients with UAP. Altogether, 11,944 patients were included, of whom 1,253 (10%) received a diagnosis of UAP. During a median follow-up of 3.0 years (interquartile [IQR] 1.6 to 4.7), 3,297 patients died. There was no difference comparing patients with NSTEMI with peak hs-cTnT of 15 to 49 ng/L to patients with UAP, with regards to long-term cardiovascular mortality (HR 1.15; 95% CI, 0.85 to 1.56), but the risk of recurrent myocardial infarction was higher in patients with NSTEMI (HR, 1.61; 95% CI, 1.29 to 2.00), and the risk of heart failure hospitalization slightly lower (HR 0.80, 95% CI, 0.64 to 0.99). In conclusion, patients with UAP and myocardial injury have a similar risk of death after discharge, but a lower risk of recurrent myocardial infarction and a marginally higher risk of heart failure, compared with patients with NSTEMI with moderately elevated hs-cTnT levels.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
